<DOC>
	<DOCNO>NCT02578186</DOCNO>
	<brief_summary>The present study conduct investigate impact diphenhydramine hydrochloride ability initiate sleep .</brief_summary>
	<brief_title>Evaluation Diphenhydramine Hydrochloride Effects Subjects With Occasional Sleeplessness</brief_title>
	<detailed_description>Diphenhydramine hydrochloride ( herein refer diphenhydramine ) antihistamine ethanolamine class know sleep-inducing property approve Food &amp; Drug Administration reduce time sleep onset individual difficulty fall asleep . The goal study investigate diphenhydramine versus placebo regard several sleep parameter , include time sleep onset , healthy adult subject suffer occasional sleeplessness .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>male female subject , ≥18 year age 55 year age , report currently experience occasional sleeplessness characterize difficulty initiate sleep ( ie , take ≥30 minute fall asleep ) average 24 time per week le 1 month ; good general health without clinically significant disease ( previously diagnose sleep disorder ) ; female , negative screening pregnancy test agree approve method birth control throughout study clinically significant illness within 30 day Screening ; take medication could interfere study medication ; clinician 's care insomnia treatment control within past year history insomnia currently take prescription medication insomnia ; currently take medication know effect sleep function ; current past history serious , severe unstable physical psychiatric illness ; current diagnosis severe urinary retention ; current diagnosis untreated narrow angle glaucoma ; participated clinical drug study use investigational new drug previous 30 day ; clinically significant abnormal find physical examination , vital sign , ECG , clinical laboratory test may affect subject 's safety outcome study ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>